...
首页> 外文期刊>Neuroscience and behavioral physiology >Motor and cognitive functions of the neostriatum during bilateral blockade of its dopamine receptors
【24h】

Motor and cognitive functions of the neostriatum during bilateral blockade of its dopamine receptors

机译:多巴胺受体双侧阻断期间新纹状体的运动和认知功能

获取原文
获取原文并翻译 | 示例

摘要

Studies on 60 Sprague-Dawley rats were performed to compare systemic and intrastriate administration of the selective D1 dopamine receptor blocker SCH23390 on the acquisition of a discriminant conditioned active avoidance reflex (CAAR) in a T maze and on behavior in an open field test. Systemic treatment at a dose of 0.025 mg/kg produced several-fold reductions in the proportion of correct performances of the discriminant CAAR and motor activity in the open field test. At the same time, bilateral microinjection of SCH23390 into the rat neostriatum at doses of 0.004–1.0 μg did not induce any deterioration in learning of the discriminant CAAR as compared with intact controls, though there was a sharp inhibition of motor activity in the open field test. Bilateral microinjections of the D2 dopamine receptor blocker raclopride into the rat neostriatum at a dose of 0.004 μg produced a marked and long-lasting degradation of learning of the discriminant CAAR. These data lead to the following conclusions: 1) the differences in the effects of systemic and intrastriate administration of SCH23390 appear to be associated with the fact that the behavioral changes seen after systemic administration may be mediated mainly by structures differing from neostriatal D1 receptors, and 2) the D1-mediated effects of the nigrostriatal dopaminergic system on the neostriatum are complex, with activation of motor activity (projection spiny neurons of the direct pathway) and weak modulation of the learning process (large aspiny cholinergic interneurons). Modulation of the learning process evidently occurs via neostriatal D2 dopaminergic receptors.
机译:进行了60只Sprague-Dawley大鼠的研究,以比较选择性D1多巴胺受体阻滞剂SCH23390在T迷宫中获得判别性条件性主动回避反射(CAAR)的行为和裸露行为中的全身性和纹状体内给药。以0.025 mg / kg的剂量进行全身治疗,可在开放视野测试中将判别CAAR的正确表现和运动活动的比例降低几倍。同时,与完整对照组相比,双侧向大鼠新纹状体双侧注射SCH23390的剂量为0.004–1.0μg,与判别CAAR的学习相比,并不会导致学习判别CAAR的任何恶化,尽管在开放视野中对运动活动有明显的抑制作用。测试。将D2多巴胺受体阻滞剂雷氯必利以0.004μg的剂量双侧显微注射到大鼠新纹状体中,导致判别CAAR的学习明显而持久地退化。这些数据得出以下结论:1)SCH23390的全身性和纹状体内给药效果的差异似乎与以下事实有关:全身性给药后所见的行为变化可能主要由不同于新纹状体D1受体的结构介导,并且2)黑纹状体多巴胺能系统对新纹状体的D1介导作用是复杂的,具有运动活动的激活(直接途径的投射棘神经元)和学习过程的弱调节(大棘突胆碱能中神经元)。学习过程的调节显然是通过新纹状体D2多巴胺能受体发生的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号